DOSSIER · UPDATED 18 NOV 2025

Abata Therapeutics

Abata Therapeutics, a company focused on translating the biology of regulatory T cells (Tregs) into transformational medicines for patients living with progressive multiple sclerosis (MS) and other severe autoimmune and inflammatory…

abatatx.com ↗Claim this profile

Founded: 2021
Headcount: 57
Open roles: 0
Last raised: Series A · $95M

SECTION I · THE BRIEF

Inside Abata Therapeutics

Brief #04651Updated 18 NOV 2025CAMBRIDGELIGHTSPEED VENTURE PARTNERSSERIES A

Employbl Dossier

Abata Therapeutics

Founded: 2021
Headcount: 57
Open roles: 0
Last raised: Series A · $95M

Section II — RestrictedMembers only

Engineering interview process at Abata Therapeutics
Tech stack & infrastructure choices
Culture & day-to-day work style
Why join now vs. 6 months from now
Hiring focus & open headcount by team
Comp philosophy and band context

Open Abata Therapeutics brief Sign in

7-day free trial · $25/mo · cancel anytime

LEADERSHIP

Founders & key people

Richard Ransohoff

OPEN ROLES

Hiring at Abata Therapeutics

Current Job Listings

Listing 0 of 0 job openings

We don't currently have any jobs listed for this company. We suggest visiting the Jobs Search page if you are looking for exciting new tech and startup opportunities.

FUNDING

Capital raised

Total Amount Raised: $95,000,000

Abata Therapeutics' Investors

Lightspeed Venture Partners

Abata Therapeutics Funding Rounds

Series A
$95,000,000
Jun 23, 2021
Series A
$95,000,000
Jun 22, 2021
Series A Investors
Third Rock Ventures
ElevateBio
Invus Group
Lightspeed Venture Partners
JDRF T1D Fund
Samsara BioCapital
Eurofarma Ventures